| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT06752668 | A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia | RECRUITING | PHASE2 | 2024-12-23 | 2025-12 | 2025-12 |
| NCT05821777 | A Study to Evaluate Safety, Tolerability and Preliminary Activity of LB101 in Participants With Advanced Solid Tumors | TERMINATED | PHASE1, PHASE2 | 2023-03-28 | 2025-09-09 | 2025-01-24 |
| NCT04985825 | Imgatuzumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma | WITHDRAWN | PHASE2 | 2021-12-16 | 2022-08-17 | 2022-08-17 |